EpCAM-Targeted Erlotinib Delivery: Enhancing Nasopharyngeal Carcinoma Treatment With Polyethylene Glycol-Coated Graphene Oxide.

Summary: Nasopharyngeal carcinoma is a challenging type of cancer affecting the area behind the nose and throat. Scientists are constantly looking for better ways to deliver drugs directly to these tumors to increase effectiveness and reduce side effects. In this study, researchers created a microscopic "delivery truck" using graphene oxide flakes. They coated these flakes to make them stable and attached a "homing beacon" (EpCAM) that specifically targets cancer cells. They then loaded this vehicle with the cancer drug Erlotinib. Tests on cancer cells and in animal models showed that this targeted delivery system successfully stopped the cancer cells from growing and spreading, offering a promising new strategy for treatment.